|
|
DYD B-11
|
|
 |
qeJKFYYEGOr |
 |
384 |
|
 |
| I'd like to cancel this standing order http://xnxx-xnxx.space/ xxnx AstraZeneca said it would pay an intial $200 million plus afurther $240 million if Spirogen meets development targets. Itwill also pay $20 million to take an equity investment in ADCTherapeutics, which has a licensing agreement with Spirogen. |
|
 |
Charlie |
 |
2019-06-15 10:24:28 |
|
|
|
|
|
|
|
|
|
